Evox Therapeutics Expands Existing Exosome Patent Portfolio With Further Grant Covering Exosomes for RNA Therapeutics |
July 15, 2020 | July 2020 Bond Updates |
OXFORD, England, July 15, 2020 /PRNewswire/ -- Evox Therapeutics Ltd ('Evox' or the 'Company'), a leading exosome therapeutics company, is pleased to announce that the Company has been granted a key patent by the United States Patent and Trademark Office (USPTO). This newly issued patent... |
View more at: https://www.prnewswire.com:443/news-releases/evox-therapeutics-expands-existing-exosome-patent-portfolio-with-further-grant-covering-exosomes-for-rna-therapeutics-301093231.html |
Related News |
|